The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

被引：0
|
作者：
Sahin, Ezgi [1 ]
Yonal-Hindilerden, Ipek [1 ]
Hindilerden, Fehmi [2 ]
Daglar-Aday, Aynur [3 ]
Nalcaci, Meliha [1 ]
机构：
[1] Istanbul Univ, Div Hematol, Dept Internal Med, Istanbul Med Fac, Istanbul, Turkey
[2] Univ Hlth Sci Bakirkoy Dr Sadi Konuk Training & R, Hematol Clin, Istanbul, Turkey
[3] Istanbul Univ, Div Med Genet, Dept Internal Med, Istanbul Med Fac, Istanbul, Turkey
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
JAK2V16F mutation; polycythemia vera; essential thrombocythemia; primary myelofibrosis; MPN;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-364
引用
收藏
页码：S337 / S338
页数：2
相关论文
共 50 条
  • [1] The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms
    Sahin, Ezgi
    Yonal-Hindilerden, Ipek
    Hindilerden, Fehmi
    Aday, Aynur
    Nalcaci, Meliha
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (01) : 150 - 165
  • [2] Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
    Yoenal-Hindilerden, Ipek
    Sahin, Ezgi
    Hindilerden, Fehmi
    Daglar-Aday, Aynur
    Nalcaci, Meliha
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 (03) : 174 - 182
  • [3] The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis
    Yonal, Ipek
    Pinarbasi, Binnur
    Hindilerden, Fehmi
    Hancer, Veysel Sabri
    Nalcaci, Meliha
    Kaymakoglu, Sabahattin
    Diz-Kucukkaya, Reyhan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (03) : 388 - 396
  • [4] Is JAK2V617F Mutation the Only Factor for Thrombosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms?
    Uyanik, Mehmet Sevki
    Baysal, Mehmet
    Pamuk, Gulsum Emel
    Maden, Muhammet
    Akker, Mustafa
    Umit, Elif Gulsum
    Demir, Muzaffer
    Aydogdu, Erkan
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 (03) : 262 - 267
  • [5] The Clinical Significance of JAK2V617F Mutation for Philadelphia-Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis
    Hindilerden, Fehmi
    Hindilerden, Ipek Yonal
    Pinarbasi, Binnur
    Hancer, Veysel Sabri
    Kaymakoglu, Sabahattin
    Kucukkaya, Reyhan Diz
    Nalcaci, Meliha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S357 - S357
  • [6] The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Yonal-Hindilerden, Ipek
    Sahin, Ezgi
    Hindilerden, Fehmi
    Daglar-Aday, Aynur
    Nalcaci, Meliha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S338 - S338
  • [7] Relationship between JAK2-V617F mutation and hematologic parameters in Philadelphia-negative chronic myeloproliferative neoplasms
    Aksit, Murat
    Bozkaya, Giray
    Uzuncan, Nuriye
    Bilgili, Sibel
    Ozlu, Can
    Aksit, Merve Zeytinli
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2020, 45 (06): : 899 - 905
  • [8] The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Ar, M. Cem
    Buyuktas, Deram
    Eskazan, A. Emre
    Aydin, Seniz Ongoren
    Tanrikulu, Eda
    Baslar, Zafer
    Buyru, A. Nur
    Ferhanoglu, Burhan
    Aydin, Yildiz
    Tuzuner, Nukhet
    Soysal, Teoman
    TURKISH JOURNAL OF HEMATOLOGY, 2012, 29 (03) : 242 - 247
  • [9] Quantification of JAK2V617F mutational burden in chronic myeloproliferative neoplasms
    Alvarez-Larran, Alberto
    MEDICINA CLINICA, 2012, 139 (09): : 393 - 394
  • [10] Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms
    Singh, Kanwaljeet
    Sazawal, Sudha
    Chhikara, Sunita
    Mahapatra, Manoranjan
    Saxena, Renu
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (03) : 371 - 374
12345